Juliette Mérian: Discussion of the Most Important Topics of Digestive Cancer Care at ESMO GI 2026
Juliette Mérian, Global Patient Affairs Director Oncology at Servier, shared a post on LinkedIn: “Back from ESMO GI 2026 and inspired by the 11th DiCE Masterclass in Munich! Over few […]
Read the full articleYou might also wanna read
La junta directiva de OHSU inaugura la era del Knight Cancer Group con aprobación y estructura de gobierno
Una nueva estructura le da al Knight Cancer Institute mayor autoridad y autonomía para crear una experiencia para pacientes de la más alta c
Personalized Treatment Strategies for HER2-Positive Gastroesophageal Adenocarcinoma
Stay current with evolving strategies for HER2-positive gastroesophageal adenocarcinoman (GEA). Improve your practice with continuing educat
mdsc.pe·20d ago
Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer
How confident are you navigating biomarker conversations with your gastric cancer patients?
mdsc.pe·20d agoA Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
Conditions : Gastrointestinal Tumor; Solid Tumor Interventions : Drug: SI-B036 Sponsors : Sichuan Baili Pharmaceutical Co., Ltd.; Baili-Bio
EsSalud habría ejecutado una adquisición millonaria de medicamentos en stock, no prioritarios para pacientes con cáncer
Informe del programa dominical Punto Final, expone una grave crisis en EsSalud, donde pacientes con cáncer denuncian falta de medicamentos e
Bioptimus to Expand AI-Based Tissue Atlas with French GI Cancer Network
The agreement gives France’s Bioptimus access to clinical trial data from more than 3,000 gastrointestinal cancer patients, including spatia
Comments
Sign in to join the conversation.
No comments yet. Be the first.